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ABSTRACT
Purpose: Trachoma is to be eliminated as a public health problem by 2020. To help the process of
planning interventions where needed, and to provide a baseline for later comparison, we set out
to complete the map of trachoma in Afar, Ethiopia, by estimating trachoma prevalence in
evaluation units (EUs) of grouped districts (“woredas”).
Methods: We conducted seven community-based surveys from August to October 2013, using
standardised Global Trachoma Mapping Project (GTMP) survey methodologies.
Results: We enumerated 5065 households and 18,177 individuals in seven EUs covering 19 of
Afar’s 29 woredas; the other ten were not accessible. 16,905 individuals (93.0%) were examined, of
whom 9410 (55.7%) were female. One EU incorporating four woredas (Telalak, Dalefage, Dewe,
Hadele Ele) was shown to require full implementation of the SAFE strategy for three years before
impact survey, with a trachomatous inflammation-follicular (TF) prevalence in 1–9-year-olds of
17.1% (95%CI 9.4–25.5), and a trichiasis prevalence in adults aged ≥15 years of 1.2% (95%CI 0.6–
2.0). Five EUs, covering 13 woredas (Berahle, Aba’ala, Dupti, Kurri, Elidihare, Ayesayeta, Afamboo,
Bure Mudaitu, Gewane, Amibara, Dulecho, Dalolo, and Konebo), had TF prevalences in children of
5–9.9% and need one round of azithromycin mass treatment and implementation of the F and E
components of SAFE before re-survey; three of these EUs had trichiasis prevalences in adults
≥0.2%. The final EU (Mile, Ada’ar) had a sub-threshold TF prevalence and a trichiasis prevalence in
adults just >0.2%.
Conclusion: Trachoma is a public health problem in Afar, and implementation of the SAFE
strategy is required.
KEYWORDS
Trachoma; trichiasis;
trachomatous inflammation-
follicular; prevalence; Afar;
Ethiopia; Global Trachoma
Mapping
Introduction
Trachoma is the world’s leading infectious cause of
blindness . An estimated 3.2 million people are thought
to have trichiasis, the potentially blinding stage of the
disease.1 Trachoma limits access to education and pre-
vents individuals from being able to work or care for
themselves or their families, and can destroy the eco-
nomic well-being of entire communities, keeping
families shackled within a cycle of poverty as the dis-
ease and its long-term effects pass from one generation
to the next. Ethiopia is considered to have the highest
prevalence of trachoma of any country, with a survey in
2005–2006 carried out at national level estimating an
overall prevalence of active trachoma of 40.1% in chil-
dren aged 1–9 years.2
The Afar Region in the North-East of Ethiopia has a
population of 1.7 million people, with the lowest popula-
tion density of any region in Ethiopia.3 The region is one
of extremes, playing host to the hottest inhabited place on
earth, the Danakil Depression, where daytime tempera-
tures reach up to 54°C, along with the active volcano Erta
Ale. The topography ranges from desert plains in the
north-east to fertile river flats and foothills on the western
boundary with Oromia, Tigray andAmhara Regions. 90%
of the population are pastoralists4 relying on highly vul-
nerable water sources—a factor that is commonly asso-
ciated with a high prevalence of trachoma.5 In the
2005–2006 survey, the estimated prevalence of active tra-
choma was only 1.9% among children aged 1–9 years in
Afar, but with only a total of 350 households visited in ten
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clusters across the whole of the Afar Region, finer resolu-
tion surveys are needed to provide appropriate data for
trachoma intervention planning.
The clinical signs of trachoma can be readily identi-
fied by trained healthcare workers using the World
Health Organization’s simplified trachoma grading
system.6,7 Conjunctival Chlamydia trachomatis infection
in children may manifest as small white follicles in the
central zone of the upper tarsal conjunctiva; if 5 or more
follicles (each of ≥0.5mm diameter) are present then
trachomatous inflammation–follicular (TF) is said to be
present. Repeat infections can lead to scarring of the
tarsal conjunctiva that can produce changes to the func-
tion and morphology of the eyelid, such that eyelashes
are mis-directed to touch the globe. This is known as
trachomatous trichiasis. Over time, persistent abrasion
by eyelashes may lead to opacification of the normally
clear cornea, with associated visual disturbance or blind-
ness, for which there is currently no cure.6,7
We conducted seven population-based prevalence
surveys in evaluation units (EUs) of grouped districts
(woredas) to complete the map of trachoma in all
accessible and secure woredas in Afar Region
(Figure 1). The objectives in each EU were to estimate
the baseline prevalence of TF in children aged
1–9 years, and to estimate the baseline prevalence of
trichiasis in those aged 15 years or greater.
Methods
The study was carried out as seven independent cross-
sectional, community-based surveys, as part of the Global
Trachoma Mapping Project (GTMP)8, using a standar-
dised methodology common to all GTMP surveys.9 We
created EUs covering all of rural Afar Region, but due to
insecurity and flooding, completing surveys in 10 woredas
was not possible. The sample size of 1019 children aged
1–9 years per EU allows estimation of a TF prevalence of
10% with a precision of +/-3%, with 95% confidence.
From the latest available census data10, it was anticipated
that 25 clusters of 30 households would be sufficient to
achieve this number. The sample size for trichiasis esti-
mates was all adults present and consenting to examina-
tion in sampled households.
Survey teams comprised a trachoma grader, a data
recorder, and a driver. Both graders (ophthalmic
nurses) and recorders were required to pass a standar-
dised (version 1) GTMP training course with exit
examination, as previously described.9
A two-stage sampling methodology was used.9
Kebeles were used as the primary sampling unit. A
list of all rural kebeles and their populations was
obtained from the health office of each respective
woreda. Kebeles were selected with probability propor-
tional to their population size, to allow equal weighting
of all individuals in each EU. At the second stage, Gots
(kebele sub-divisions of approximately 30 households)
were randomly selected by drawing lots on the day of
survey. All households in a sampled got were included,
with all residents in sampled households aged 1 year
and above enumerated.
Verbal consent for examination was recorded for indi-
viduals present. GPS coordinates of each household were
recorded at the time of survey. All consenting participants
were examined for clinical signs of trachoma using the
WHO simplified trachoma grading system.6,7 All data
were recorded on a smartphone using an electronic data
collection tool developed for the survey (LINKS,
Taskforce for Global Health, Decatur, USA).
Data analysis
Data were analysed according to GTMP protocols.9 TF
prevalence was adjusted for age in 1 year age bands,
and trichiasis prevalence was adjusted for sex and age
in 5 year age bands using the 2007 Afar Census data.10
Outcomes were adjusted at kebele (cluster)-level to
account for the clustered design of the surveys, with
each EU outcome prevalence being the mean of all
constituent adjusted kebele-level proportions. This
was carried out to reduce the variance of population-
level estimates of survey outcomes, where the sampled
population may be non-representative through stochas-
tic variation or sampling bias.11 The mean of all EU-
level outcome estimates was used to estimate overall
outcomes for this series of seven surveys, with confi-
dence intervals estimated by bootstrapping cluster-level
estimates, with stratification of clusters at EU-level. All
analyses were carried out in R 3.0.2 (R Foundation for
Statistical Computing, 2013).9
Ethical considerations
Ethical approval was obtained from the ethics commit-
tees of the Afar Regional Health Bureau and the
London School of Hygiene & Tropical Medicine
(6319). Permission to undertake the survey was
obtained from each respective zone, woreda and kebele
office. Communities were sensitised in advance to the
purpose and procedures for the survey. Informed verbal
consent was obtained from each individual aged
≥15 years. In those under 15 years of age, informed
verbal consent was obtained from a parent or guardian.
All individuals with active trachoma identified through
the surveys were provided with 1% tetracycline eye
ointment to apply twice daily for 6 weeks, and those
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with trichiasis were referred to the nearest health insti-
tution for surgical correction. Residents of selected gots
had the right not to participate in the survey, not to
respond to uncomfortable questions and to stop
responding to questions or terminate examination at
any time that they wanted to stop, without impacting
on their normal health care.
Results
A total of 18,177 people were enumerated over 7 EUs
covering 19 woredas. 5065 households were visited in a
total of 178 clusters from 13th August, 2013 to 6th
October, 2013. Details of individuals enumerated in
the 7 EUs surveyed are shown in Table 1.
The overall adjusted prevalence of TF in children
aged 1–9 years for the 7 EUs combined was 8.2% (95%
CI 6.5–10.0%), although there was considerable variation
in adjusted prevalence between EUs. The lowest adjusted
TF prevalence (4.1%, 95%CI 2.1–6.8) was reported in the
EU covering Mile and Ada’ar woredas. The highest
adjusted prevalence of TF (17.1%, 95%CI 9.4–25.5) was
found in the EU covering the Telalak, Delefage, Dewe
and Hadele Ele woredas (Table 2, Figure 2).
A total of 103 cases of trichiasis were identified in
the 7 surveys in those aged 15 years or greater, with the
Figure 1. Administrative woredas and evaluation units, Global Trachoma Mapping Project, Afar, Ethiopia, 2013.
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overall prevalence in those aged 15 years or greater in
the area surveyed estimated to be 0.5%. The lowest
adjusted trichiasis prevalence in those aged 15 years
or greater (0.1%) was in the EU covering Dupti and
Kurii woredas. The highest adjusted trichiasis preva-
lence was found in the two Eus covering Telalak,
Delefage, Dewe, and Hadele Ele woredas, and Bure
Mudaitu, Gewane, Amibara, and Dulecho woredas,
both of which had an estimated adjusted trichiasis
prevalence of 1.2%. (Table 3, Figure 3).
Discussion
When compared to EUs in several other regions of
Ethiopia involved in the GTMP12–14, or Amhara
Region15, the prevalences of trachoma in Afar EUs
were low, though the relatively low prevalences are
matched in data from northern Ethiopian Somali
Region16, to which Afar is also adjacent. Studies
have previously associated trachoma with hot, dry
areas with relative water scarcity.17–19Afar has very
low levels of access to water and sanitation2, and the
average temperature are amongst the highest in the
world. It is possible that very high temperatures limit
the breeding potential of the flies that are thought to
spread trachoma.20 Large scale spatial variation in
risk of trachoma has been studied elsewhere, notably
in Nigeria21, although there, interestingly, risk of
trichiasis was higher with higher mean annual tem-
perature—albeit within a considerably cooler range
(21.8–28.7°C) than experienced in Afar. Aspects of
the Afari culture may also play a part. For example,
in the last census10, 96% of the population of Afar
identified themselves as Muslim, and ritual washing
associated with daily prayer may limit spread of
infection. However, this is speculation; data on beha-
viour were not collected as part of our surveys.
World Health Organization (WHO) targets for tra-
choma elimination are a TF prevalence <5% in chil-
dren, and a trichiasis prevalence <0.2% in those aged
15 years or greater (equivalent to a trichiasis prevalence
of <0.1% of the total population).22 In these surveys,
one EU covering two woredas (Mile and Ada’ar) had a
prevalence of TF in children below 5%, but a preva-
lence of trichiasis in adults just greater than 0.2%. Only
one EU, comprising the woredas Telalak, Dalefage,
Dewe and Hadele Ele, had a TF prevalence above the
10% level at which mass drug administration (MDA)
with azithromycin is recommended for three or more
years.23 The relatively high prevalence in this EU might
be because it shares a boundary with Amhara Region. It
also might be attributed to similar weather, culture, or
geography, factors related to any or all of which could
be conducive to transmission.17–20 The boundaries
between Afar and Amhara are not clearly defined by
the local population, the majority of whom are pastor-
alists undertaking seasonal migrations between Afar
and the highland areas of Amhara in search of grazing
land and water. Whilst Amhara has had an active
trachoma elimination programme for many years,
Table 1. Individuals enumerated in seven trachoma prevalence surveys, Global Trachoma Mapping Project, Afar, Ethiopia, 2013.
Individuals
Evaluation unit
Total
Population
Kebeles
(n)
Households
(n)
Total residents
(n)
Absent
(n)
Refused
(n)
Examined (n,
%)
Berahle, Aba’ala 116,844 25 732 2763 228 24 2511 (90.9)
Mile, Ada’ar 90,673 23 770 2869 169 25 2675 (93.2)
Dupti, Kurri 95,994 27 706 2578 179 40 2359 (91.5)
Elidihare, Ayesayeta, Afamboo 133,043 26 724 2592 174 29 2389 (92.2)
Bure Mudaitu, Gewane, Amibara, Dulecho 146,577 25 720 2579 82 18 2479 (96.1)
Dalolo, Konebo 138,128 26 725 2518 167 11 2340 (92.9)
Telalak, Dalefage, Dewe, Hadele Ele 116,521 26 688 2278 114 12 2152 (94.5)
Total 837,780 178 5065 18177 1113 159 16905 (93.0)
Table 2. Prevalence of trachomatous inflammation –follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project,
Afar, Ethiopia, 2013.
Evaluation unit Examined (n) TF cases (n) Unadjusteda TF (%) Adjustedb TF (%) 95% CIc
Berahle, Aba’ala 1041 117 11.2 8.7 [5.2–12.4]
Mile, Ada’ar 1007 41 4.1 4.1 [2.1–6.8]
Dupti, Kurri 861 73 8.5 7.2 [4.1–11.5]
Elidihare, Ayesayeta, Afamboo 807 57 7.1 6.3 [3.4–10.2]
Bure Mudaitu, Gewane, Amibara, Dulecho 915 74 8.1 6.5 [3.8–9.6]
Dalolo, Konebo 925 87 9.4 7.7 [5.1–11.2]
Telalak, Dalefage, Dewe, Hadele Ele 843 162 19.2 17.1 [9.4–25.5]
Total 6399 611 9.5 8.2 -
acrude prevalence estimate (total cases/total examined)
badjusted at cluster-level for age in one year age bands, with the overall adjusted prevalence being the mean of all such estimates in a given evaluation unit
c95% confidence interval obtained by bootstrapping adjusted cluster-level proportions over 10,000 iterations, and taking the 2.5th and 97.5th centiles.
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Afar has not, and these migrations might contribute to
the continuing presence of trachoma in both areas.
Five EUs (made up of 13 woredas) had TF preva-
lences in children between 5 and 9.9%. The current
practice of the International Trachoma Initiative for
such EUs is to make available a single round of azi-
thromycin MDA24, which should be given alongside
implementation of the F and E components of the
SAFE strategy, and followed by repeat survey. Given
the close proximity of these woredas to Amhara,
coordination between the regions may be important.
The estimates for trichiasis prevalence have con-
fidence intervals much larger than those for the TF
estimates. This is because a larger sample size is
needed to give precise estimates for rarer outcomes,
particularly at the 0.2% elimination threshold for
trichiasis around which public health-level interven-
tion decisions are made. For reasons of practicality,
the sample size used for the trichiasis prevalence
estimates for each EU was all those aged ≥15 years
in enumerated households. These are population-
based samples, not convenience samples, but they
Figure 2. Prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project,
Afar, Ethiopia, 2013.
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Table 3. Prevalence of trichiasis in those aged 15 years or greater, Global Trachoma Mapping Project, Afar, Ethiopia, 2013.
Evaluation unit Examined (n) Trichiasis cases (n) Unadjusteda trichiasis (%) Adjustedb trichiasis (%) 95%CIc
Berahle, Aba’ala 1243 14 1.1 0.5 [0.2–1.0]
Mile, Ada’ar 1370 8 0.6 0.2d [0.0–0.5]
Dupti, Kurri 1308 6 0.5 0.1 [0.0–0.4]
Elidihare, Ayesayeta, Afamboo 1408 7 0.5 0.2e [0.1–0.4]
Bure Mudaitu, Gewane, Amibara, Dulecho 1329 26 2 1.2 [0.6–1.6]
Dalolo, Konebo 1219 13 1.1 0.3 [0.1–0.5]
Telalak, Dalefage, Dewe, Hadele Ele 1135 29 2.6 1.2 [0.6–2.0]
Total 9012 103 1.1 0.5 -
acrude prevalence estimate (total cases/total examined)
badjusted at cluster-level for sex and age in 5 year age bands, with the overall adjusted prevalence being the mean of all such estimates in a given evaluation
unit
c95% confidence interval obtained by bootstrapping adjusted cluster-level proportions over 10,000 iterations, and taking the 2.5th and 97.5th centiles.
drounded down to 0.2%; erounded up to 0.2%
Figure 3. Prevalence of trichiasis in those aged 15 years or greater, Global Trachoma Mapping Project, Afar, Ethiopia, 2013.
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provide estimates with relatively low repeatability.
Despite this limitation, it is hoped that they are
useful as a guide for programme managers.
Though we present overall TF and trichiasis estimates
for our series of surveys, in Tables 2 and 3 and in the
results section above, these should not be interpreted as
region-level prevalences: not all of Afar has been sur-
veyed here, and the areas for which we have data are not
all contiguous. We could not access ten woredas during
scheduled mapping in the region, due to inaccessibility
and insecurity. Plans are currently being developed to
undertake surveys in these woredas. Completion of the
baseline map in Afar will facilitate planning for regional
trachoma elimination.
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